These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 26382761)
1. Efficacy and Safety of Antifibrinolytic Agents in Reducing Perioperative Blood Loss and Transfusion Requirements in Scoliosis Surgery: A Systematic Review and Meta-Analysis. Wang M; Zheng XF; Jiang LS PLoS One; 2015; 10(9):e0137886. PubMed ID: 26382761 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of antifibrinolytic agents on surgical bleeding and transfusion requirements in spine surgery: a meta-analysis. Li G; Sun TW; Luo G; Zhang C Eur Spine J; 2017 Jan; 26(1):140-154. PubMed ID: 27671279 [TBL] [Abstract][Full Text] [Related]
3. Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children. Tzortzopoulou A; Cepeda MS; Schumann R; Carr DB Cochrane Database Syst Rev; 2008 Jul; (3):CD006883. PubMed ID: 18646174 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of tranexamic acid in reducing blood loss in scoliosis surgery: a systematic review and meta-analysis. Yuan QM; Zhao ZH; Xu BS Eur Spine J; 2017 Jan; 26(1):131-139. PubMed ID: 27900553 [TBL] [Abstract][Full Text] [Related]
5. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; Fergusson DA; Ker K Cochrane Database Syst Rev; 2011 Jan; (1):CD001886. PubMed ID: 21249650 [TBL] [Abstract][Full Text] [Related]
6. Are antifibrinolytics helpful in decreasing blood loss and transfusions during spinal fusion surgery in children with cerebral palsy scoliosis? Dhawale AA; Shah SA; Sponseller PD; Bastrom T; Neiss G; Yorgova P; Newton PO; Yaszay B; Abel MF; Shufflebarger H; Gabos PG; Dabney KW; Miller F Spine (Phila Pa 1976); 2012 Apr; 37(9):E549-55. PubMed ID: 22037532 [TBL] [Abstract][Full Text] [Related]
7. The relative efficacy of antifibrinolytics in adolescent idiopathic scoliosis: a prospective randomized trial. Verma K; Errico T; Diefenbach C; Hoelscher C; Peters A; Dryer J; Huncke T; Boenigk K; Lonner BS J Bone Joint Surg Am; 2014 May; 96(10):e80. PubMed ID: 24875032 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of tranexamic acid in reducing allogeneic blood products in adolescent idiopathic scoliosis surgery. Sui WY; Ye F; Yang JL BMC Musculoskelet Disord; 2016 Apr; 17():187. PubMed ID: 27117696 [TBL] [Abstract][Full Text] [Related]
9. Role of Amicar in surgery for neuromuscular scoliosis. Thompson GH; Florentino-Pineda I; Poe-Kochert C; Armstrong DG; Son-Hing J Spine (Phila Pa 1976); 2008 Nov; 33(24):2623-9. PubMed ID: 18981961 [TBL] [Abstract][Full Text] [Related]
10. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; Fergusson DA; Ker K Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD001886. PubMed ID: 21412876 [TBL] [Abstract][Full Text] [Related]
11. A systematic review and meta-analysis of the use of antifibrinolytic agents in total hip arthroplasty. Huang F; Wu Y; Yin Z; Ma G; Chang J Hip Int; 2015; 25(6):502-9. PubMed ID: 26620803 [TBL] [Abstract][Full Text] [Related]
12. The role of Amicar in same-day anterior and posterior spinal fusion for idiopathic scoliosis. Thompson GH; Florentino-Pineda I; Poe-Kochert C; Armstrong DG; Son-Hing JP Spine (Phila Pa 1976); 2008 Sep; 33(20):2237-42. PubMed ID: 18794767 [TBL] [Abstract][Full Text] [Related]
13. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; McClelland B; Laupacis A; Fergusson D Cochrane Database Syst Rev; 2007 Oct; (4):CD001886. PubMed ID: 17943760 [TBL] [Abstract][Full Text] [Related]
14. The effect of amicar on perioperative blood loss in idiopathic scoliosis: the results of a prospective, randomized double-blind study. Florentino-Pineda I; Thompson GH; Poe-Kochert C; Huang RP; Haber LL; Blakemore LC Spine (Phila Pa 1976); 2004 Feb; 29(3):233-8. PubMed ID: 14752343 [TBL] [Abstract][Full Text] [Related]
15. Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children. McNicol ED; Tzortzopoulou A; Schumann R; Carr DB; Kalra A Cochrane Database Syst Rev; 2016 Sep; 9(9):CD006883. PubMed ID: 27643712 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of antifibrinolytic agents in spinal surgery: a network meta-analysis. Yuan L; Zeng Y; Chen ZQ; Zhang XL; Mai S; Song P; Tao LY Chin Med J (Engl); 2019 Mar; 132(5):577-588. PubMed ID: 30807356 [TBL] [Abstract][Full Text] [Related]
17. Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery? A meta-analysis of randomized head-to-head trials. Carless PA; Moxey AJ; Stokes BJ; Henry DA BMC Cardiovasc Disord; 2005 Jul; 5():19. PubMed ID: 15992412 [TBL] [Abstract][Full Text] [Related]
18. Tranexamic acid diminishes intraoperative blood loss and transfusion in spinal fusions for duchenne muscular dystrophy scoliosis. Shapiro F; Zurakowski D; Sethna NF Spine (Phila Pa 1976); 2007 Sep; 32(20):2278-83. PubMed ID: 17873823 [TBL] [Abstract][Full Text] [Related]
19. Perioperative blood transfusion requirements in pediatric scoliosis surgery: the efficacy of tranexamic acid. Grant JA; Howard J; Luntley J; Harder J; Aleissa S; Parsons D J Pediatr Orthop; 2009; 29(3):300-4. PubMed ID: 19305284 [TBL] [Abstract][Full Text] [Related]
20. Can tranexamic acid conserve blood and save operative time in spinal surgeries? A meta-analysis. Hui S; Xu D; Ren Z; Chen X; Sheng L; Zhuang Q; Li S Spine J; 2018 Aug; 18(8):1325-1337. PubMed ID: 29246849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]